152 related articles for article (PubMed ID: 10423643)
21. Therapeutic effects of evening administration of guanabenz and clonidine on morning hypertension: evaluation using home-based blood pressure measurements.
Hashimoto J; Chonan K; Aoki Y; Ugajin T; Yamaguchi J; Nishimura T; Kikuya M; Michimata M; Matsubara M; Araki T; Hozawa A; Ohkubo T; Imai Y
J Hypertens; 2003 Apr; 21(4):805-11. PubMed ID: 12658028
[TBL] [Abstract][Full Text] [Related]
22. Transdermal administration of clonidine for treatment of high BP.
Weber MA; Drayer JI; McMahon FG; Hamburger R; Shah AR; Kirk LN
Arch Intern Med; 1984 Jun; 144(6):1211-3. PubMed ID: 6375613
[TBL] [Abstract][Full Text] [Related]
23. Transdermal clonidine therapy in hypertensive patients. Effects on office and ambulatory recorded blood pressure values.
Schaller MD; Nussberger J; Waeber B; Porchet M; Brunner HR
JAMA; 1985 Jan; 253(2):233-5. PubMed ID: 3965774
[TBL] [Abstract][Full Text] [Related]
24. Sex- and age-related antihypertensive effects of amlodipine. The Amlodipine Cardiovascular Community Trial Study Group.
Kloner RA; Sowers JR; DiBona GF; Gaffney M; Wein M
Am J Cardiol; 1996 Apr; 77(9):713-22. PubMed ID: 8651122
[TBL] [Abstract][Full Text] [Related]
25. Triple-combination treatment with olmesartan medoxomil/amlodipine/ hydrochlorothiazide in Hispanic/Latino patients with hypertension: the TRINITY study.
Lewin AJ; Kereiakes DJ; Chrysant SG; Izzo JL; Oparil S; Lee J; Fernandez V; Melino M
Ethn Dis; 2014; 24(1):41-7. PubMed ID: 24620447
[TBL] [Abstract][Full Text] [Related]
26. The USA experience with the clonidine transdermal therapeutic system.
Burris JF
Clin Auton Res; 1993 Dec; 3(6):391-6. PubMed ID: 8193527
[TBL] [Abstract][Full Text] [Related]
27. Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial.
Webster R; Salam A; de Silva HA; Selak V; Stepien S; Rajapakse S; Amarasekara S; Amarasena N; Billot L; de Silva AP; Fernando M; Guggilla R; Jan S; Jayawardena J; Maulik PK; Mendis S; Mendis S; Munasinghe J; Naik N; Prabhakaran D; Ranasinghe G; Thom S; Tisserra N; Senaratne V; Wijekoon S; Wijeyasingam S; Rodgers A; Patel A;
JAMA; 2018 Aug; 320(6):566-579. PubMed ID: 30120478
[TBL] [Abstract][Full Text] [Related]
28. Transdermal clonidine (Catapres-TTS) monotherapy in the management of mild hypertension in general practice.
Lewis GR
N Z Med J; 1987 Nov; 100(836):711-3. PubMed ID: 3330602
[TBL] [Abstract][Full Text] [Related]
29. Phase IV, 8-week, multicenter, randomized, active treatment-controlled, parallel group, efficacy, and tolerability study of high-dose candesartan cilexetil combined with hydrochlorothiazide in Korean adults with stage II hypertension.
Lee HY; Hong BK; Chung WJ; Lee BK; Lee SH; Jeon DW; Ahn YK; Kim D; Park CK; Kim SH; Jung HO; Kim BO; Choi D
Clin Ther; 2011 Aug; 33(8):1043-56. PubMed ID: 21831438
[TBL] [Abstract][Full Text] [Related]
30. Improving compliance in an inner-city hypertensive patient population.
Branche GC; Batts JM; Dowdy VM; Field LS; Francis CK
Am J Med; 1991 Jul; 91(1A):37S-41S. PubMed ID: 1867227
[TBL] [Abstract][Full Text] [Related]
31. Utility of a transdermal delivery system for antihypertensive therapy. Part 1.
Sclar DA; Skaer TL; Chin A; Okamoto MP; Gill MA
Am J Med; 1991 Jul; 91(1A):50S-56S. PubMed ID: 1907801
[TBL] [Abstract][Full Text] [Related]
32. Transdermal clonidine for hypertensive patients.
Popli S; Stroka G; Ing TS; Daugirdas JT; Norusis MJ; Hano JE; Gandhi VC
Clin Ther; 1983; 5(6):624-8. PubMed ID: 6627288
[TBL] [Abstract][Full Text] [Related]
33. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
Ishii R; Tagawa T; Ishida T; Naruse T
Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension.
Kolloch RE; Mehlburger L; Schumacher H; Göbel BO
Clin Auton Res; 1993 Dec; 3(6):373-8. PubMed ID: 8193524
[TBL] [Abstract][Full Text] [Related]
35. A double-blind comparison of transdermal clonidine and oral captopril in essential hypertension.
McMahon FG; Jain AK; Vargas R; Fillingim J
Clin Ther; 1990; 12(2):88-100. PubMed ID: 2191779
[TBL] [Abstract][Full Text] [Related]
36. Intrathecal Clonidine via Lumbar Puncture Decreases Blood Pressure in Patients With Poorly Controlled Hypertension.
Komanski CB; Rauck RL; North JM; Hong KS; D'Angelo R; Hildebrand KR
Neuromodulation; 2015 Aug; 18(6):499-507; discussion 507. PubMed ID: 25944733
[TBL] [Abstract][Full Text] [Related]
37. Transdermal and oral clonidine.
Lilja M; Juustila H; Sarna S; Jounela AJ
Ann Med; 1991 Aug; 23(3):265-9. PubMed ID: 1930916
[TBL] [Abstract][Full Text] [Related]
38. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
[TBL] [Abstract][Full Text] [Related]
39. Long-term (5 year) experience with transdermal clonidine in the treatment of mild to moderate hypertension.
Breidthardt J; Schumacher H; Mehlburger L
Clin Auton Res; 1993 Dec; 3(6):385-90. PubMed ID: 8193526
[TBL] [Abstract][Full Text] [Related]
40. Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial.
Everett BM; Glynn RJ; Danielson E; Ridker PM;
Clin Ther; 2008 Apr; 30(4):661-72. PubMed ID: 18498915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
